Evvy
12 known investors
Evvy is an AI-powered precision medicine platform using vaginal microbiome testing and analysis to diagnose and treat women's health conditions including vaginal health, fertility, and menopause. The platform translates vaginal microbiome data into personalized care pathways and novel biomarker discovery for women who have historically been excluded from clinical research.
Founders & leadership
Investors · 12
Also in the syndicate · 2
Funding
SEC filings, press & company announcements$14M disclosed across 1 round · 2023
- $14MSeries ASep 2023 · 2 sources
Left Lane Capital (lead), Amboy Street Ventures, G9 Ventures, General Catalyst, Ingeborg Investments, Labcorp Venture Fund, RH Capital, Virtue
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 3
by search overlapCompanies competing with Evvy for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Juno Bio Raises $3.8M to Expand Vaginal Microbiome Testing | Fitt Insiderinsider.fitt.co · Jul 2026Frequently asked questions
- What does Evvy do?
- Evvy is an AI-powered precision medicine platform using vaginal microbiome testing and analysis to diagnose and treat women's health conditions including vaginal health, fertility, and menopause. The platform translates vaginal microbiome data into personalized care pathways and novel biomarker discovery for women who have historically been excluded from clinical research.
- Who founded Evvy?
- Evvy was founded by Priyanka Jain, Laine Bruzek.
- Who are Evvy's investors?
- Evvy's investors include Amboy Street Ventures, Foreground Capital, Ingeborg Investments, Left Lane Capital, Virtue Ventures, BBG Ventures, G9 Ventures, General Catalyst and 2 more.
- How much funding has Evvy raised?
- Evvy has disclosed $14M raised across 1 round.




.png)


.png)
